Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Practice: Five Things to Know About ...

High-flow nasal oxygen therapy in adults with hypoxemia

Michael C. Sklar and Laveena Munshi
CMAJ November 11, 2019 191 (45) E1250; DOI: https://doi.org/10.1503/cmaj.191021
Michael C. Sklar
Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ont.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laveena Munshi
Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ont.
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

High-flow nasal oxygen therapy allows delivery of heated, humidified oxygen at flow rates of up to 60 L/min

In the setting of acute respiratory failure, patients may generate inspiratory flow rates greater than the flow capacity of conventional oxygen devices. Entrainment of room air may occur, diluting the intended concentration of oxygen.1 Oxygen delivery at higher flows, through high-flow nasal oxygen, can better match inspiratory flows generated, thus enabling more precise delivery of intended oxygen concentrations.2

High-flow nasal oxygen has unique physiologic properties

The mechanisms of benefit are multifactorial and include higher flow rates of oxygen delivery, carbon dioxide washout of nasopharyngeal dead space, humidification allowing for improved secretion clearance and decreased bronchoconstriction, and generation of positive end-expiratory pressure (Appendix 1, available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.191021/-/DC1).2

High-flow nasal oxygen can be used in a variety of clinical situations

Several studies have shown consistent reduction in work of breathing and respiratory rate in the setting of respiratory distress.3 Evidence suggests possible benefit by improving oxygenation in acute hypoxemic respiratory failure, reducing the need for intubation and 90-day mortality.1,4 High-flow nasal oxygen therapy has also been found to reduce hypoxemia during intubation and after extubation.1

High-flow nasal oxygen should be used only in highly monitored settings

High-flow nasal oxygen should be restricted to settings with high-acuity monitoring, such as emergency departments, operating rooms and intensive care units. Clinical deterioration of a patient receiving high-flow nasal oxygen (or inadvertent oxygen disconnection) is a medical emergency given the acuity of such a patient with potentially minimal respiratory reserve.1

Potential uses of high-flow nasal oxygen are still expanding

A randomized controlled trial showed survival benefit in acute respiratory failure when high-flow nasal oxygen was compared with face-mask or noninvasive ventilation.4 There is evolving evidence for its use in the extubation management of patients at high risk of extubation failure.1,5 Other potential roles exist, including during procedural sedation, and for preoxygenation and apneic oxygenation for intubation optimization.3 The utility of high-flow nasal oxygen for hypercapnic respiratory failure, such as in chronic obstructive pulmonary disease, remains unclear but is under evaluation (ClinicalTrials.gov no. NCT03033251).

CMAJ invites submissions to “Five things to know about …” Submit manuscripts online at http://mc.manuscriptcentral.com/cmaj

Footnotes

  • CMAJ Podcasts: author interview at https://soundcloud.com/cmajpodcasts/191021-five

  • Competing interests: None declared.

  • This article has been peer reviewed.

References

  1. ↵
    1. Rochwerg B,
    2. Granton D,
    3. Wang DX,
    4. et al
    . High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med 2019; 45:563–72.
    OpenUrl
  2. ↵
    1. Goligher EC,
    2. Slutsky AS
    . Not just oxygen? Mechanisms of benefit from high-flow nasal cannula in hypoxemic respiratory failure. Am J Respir Crit Care Med 2017;195: 1128–31.
    OpenUrl
  3. ↵
    1. Papazian L,
    2. Corley A,
    3. Hess D,
    4. et al
    . Use of high-flow nasal cannula oxygenation in ICU adults: a narrative review. Intensive Care Med 2016;42:1336–49.
    OpenUrl
  4. ↵
    1. Frat J-P,
    2. Thille AW,
    3. Mercat A,
    4. et al
    . High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372:2185–96.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Stéphan F,
    2. Barrucand B,
    3. Petit P,
    4. et al
    . High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial. JAMA 2015;313:2331–9.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 191 (45)
CMAJ
Vol. 191, Issue 45
11 Nov 2019
  • Table of Contents
  • Index by author

Podcast

Subscribe to podcast
Download MP3

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
High-flow nasal oxygen therapy in adults with hypoxemia
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
High-flow nasal oxygen therapy in adults with hypoxemia
Michael C. Sklar, Laveena Munshi
CMAJ Nov 2019, 191 (45) E1250; DOI: 10.1503/cmaj.191021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
High-flow nasal oxygen therapy in adults with hypoxemia
Michael C. Sklar, Laveena Munshi
CMAJ Nov 2019, 191 (45) E1250; DOI: 10.1503/cmaj.191021
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • High-flow nasal oxygen therapy allows delivery of heated, humidified oxygen at flow rates of up to 60 L/min
    • High-flow nasal oxygen has unique physiologic properties
    • High-flow nasal oxygen can be used in a variety of clinical situations
    • High-flow nasal oxygen should be used only in highly monitored settings
    • Potential uses of high-flow nasal oxygen are still expanding
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Collections

  • Article Types
    • Five Things to Know About
  • Topics
    • Critical & intensive care
    • Respiratory medicine

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire